Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Formosa Pharmaceuticals, Inc.
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Expected to undergo unilateral uncomplicated cataract extraction via phacoemulsification and posterior chamber intraocular lens implantation in one eye.
In Investigator's opinion, have Early Treatment Diabetic Retinopathy Study estimated potential of 0.7 (20/100) or better in study eye.
Have \> 10 and ≤ 30 cells in anterior chamber.
Have an intraocular pressure ≤ 30 mmHg.
You may not be if
Have an anterior chamber cell count \> 0 or any evidence of intraocular inflammation.
Have a score \> 0 on Ocular Pain Assessment in either eye.
Clareo Health | A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery
